Lenvatinib (Lenvima)

[ ANTI-CANCER DRUGS ]
UNIT PRICE: 7,500.00 USD
  7,500.00 USD
In Stock

Lenvatinib (trade name Lenvima)

Related Products

Product Details

An anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
VIEW ALL PRODUCTS